SCNX
Scienture Holdings, Inc.
Pharmaceutical Retailers · Healthcare · United States
3.22
close · 2026-10-30
value
14
cheaper than peers14
quality
18
stronger fundamentals18
ranked against
Healthcare
value
quality
548 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 1 year ago | 77.0% | 100 |
| price to book | 0.08× | 100 |
| price to sales | 6.44× | 37 |
| cash flow yield, 3 years ago | -29.6% | 21 |
| cash flow yield, 2 years ago | -42.1% | 16 |
| earnings yield, latest year | -83.9% | 12 |
| earnings yield, 3 years ago | -191.0% | 10 |
| cash flow yield, 1 year ago | -269.9% | 2 |
| cash flow yield, latest year | -253.0% | 2 |
| earnings yield, 2 years ago | -725.2% | 1 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 16.7% | 59 |
| return on equity | -53.5% | 34 |
| operating margin | -785.6% | 9 |
3 of 4 measures available
Facts
| market cap | $5M |
| free cash flow | -$7.6M |
| employees | 4 |
| first trade | 2014-02-06 |
| next earnings | not reported |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.70 | 2.48 | -23.35 | -6.15 |
| free cash flow | -$13.4M | -$14.3M | -$2.2M | -$1.6M |
| net income | -$41.5M | $9.1M | -$17.8M | -$3.5M |
| revenue | $431,609 | $136,643 | $1.4M | $10.3M |
| unusual items | -$23.4M | -$2.9M | -$2.9M | -$47,506 |